FDA 483 - Korex Chicago LLC - February 07, 2025

Korex Chicago LLC, a drug manufacturer in Chicago, IL, was cited with six observations during an FDA inspection. The observations primarily concern significant deficiencies in microbiological control, cleaning validation, process control, stability testing methods, OOS investigations, and document control. These issues indicate a lack of robust quality systems and could impact drug product quality and safety.